⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

July 15, 2024

Figure S13 from ASPSCR1::TFE3 Drives Alveolar Soft Part Sarcoma by Inducing Targetable Transcriptional Programs

Ewa Sicinska Vijaya S.R. Kola Joseph A. Kerfoot Madeleine L. Taddei Alyaa Al‐Ibraheemi Yi-Hsuan Hsieh Alanna J. Church Esther Landesman‐Bollag Yosef Landesman Matthew L. Hemming

View at Publisher

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Figure S13. ATAC-seq profiles at regions of reduced DNA accessibility following dTAG13 treatment.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Sicinska et al. (2024) studied this question.

synapsesocial.com/papers/68e60477b6db64358759841a https://doi.org/10.1158/0008-5472.26302641

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Figure S14 from ASPSCR1::TFE3 Drives Alveolar Soft Part Sarcoma by Inducing Targetable Transcriptional Programs2024
2Figure S10 from ASPSCR1::TFE3 Drives Alveolar Soft Part Sarcoma by Inducing Targetable Transcriptional Programs2024
3Figure S6 from ASPSCR1::TFE3 Drives Alveolar Soft Part Sarcoma by Inducing Targetable Transcriptional Programs2024
4Figure S8 from ASPSCR1::TFE3 Drives Alveolar Soft Part Sarcoma by Inducing Targetable Transcriptional Programs2024
5Figure S15 from ASPSCR1::TFE3 Drives Alveolar Soft Part Sarcoma by Inducing Targetable Transcriptional Programs2024

Figure S17 from ASPSCR1::TFE3 Drives Alveolar Soft Part Sarcoma by Inducing Targetable Transcriptional Programs2024
Figure S9 from ASPSCR1::TFE3 Drives Alveolar Soft Part Sarcoma by Inducing Targetable Transcriptional Programs2024
Figure S16 from ASPSCR1::TFE3 Drives Alveolar Soft Part Sarcoma by Inducing Targetable Transcriptional Programs2024